Oasis Management CO Ltd. Zai Lab LTD Transaction History

Oasis Management CO Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$14.95 - $24.72 $299,000 - $494,400	-20,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$18.0 - $25.01 $360,000 - $500,200	20,000 New	20,000 $465,000
Q4 2017 Feb 14, 2018	SELL	$21.23 - $34.09 $212,300 - $340,900	-10,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$27.0 - $31.11 $270,000 - $311,100	10,000	10,000 $270,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.57B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Oasis Management CO Ltd., based on Form 13F filings with the SEC.

Stay updated on Oasis Management CO Ltd. with notifications on news.